Xenetic Biosciences annual ebitda
2012
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Xenetic Biosciences EBITDA Growth & History (XBIO)
Xenetic Biosciences's calculated EBITDA was −$2.8M for fiscal 2025.
View full Xenetic Biosciences company overviewXenetic Biosciences annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$2.8M | $1.4M | — |
| 2024 | 2024-12-31 | −$4.2M | $311,287 | — |
| 2023 | 2023-12-31 | −$4.5M | $2.2M | — |
| 2022 | 2022-12-31 | −$6.7M | −$971,143 | — |
| 2021 | 2021-12-31 | −$5.7M | $8.2M | — |
| 2020 | 2020-12-31 | −$13.9M | −$1.1M | — |
| 2019 | 2019-12-31 | −$12.9M | −$5.6M | — |
| 2018 | 2018-12-31 | −$7.3M | −$3.7M | — |
| 2017 | 2017-12-31 | −$3.5M | $43.8M | — |
| 2016 | 2016-12-31 | −$47.4M | −$37.6M | — |
| 2015 | 2015-12-31 | −$9.8M | $3.1M | — |
| 2014 | 2014-12-31 | −$12.8M | −$4.3M | — |
| 2013 · Dec 31 | 2013-12-31 | −$8.6M | −$2.3M | — |
| 2012 · Dec 31 | 2012-12-31 | −$6.2M | — | — |
| 2012 · Aug 31 | 2012-08-31 | −$97,180 | — | — |
Xenetic Biosciences quarterly ebitda
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q1.13
Q1.13
Q2.13
Q2.13
Q3.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$971,690 | −$247,278 | — |
| Q1 2026 | 2026-03-31 | −$502,117 | — | — |
| Q4 2025 | 2025-12-31 | −$623,027 | — | — |
| Q3 2025 | 2025-09-30 | −$544,734 | — | — |
| Q2 2025 | 2025-06-30 | −$724,412 | — | — |
| Q4 2021 | 2021-12-31 | −$1.9M | −$654,215 | — |
| Q3 2021 | 2021-09-30 | −$1.4M | $9.1M | — |
| Q2 2021 | 2021-06-30 | −$1.1M | −$145,392 | — |
| Q1 2021 | 2021-03-31 | −$1.4M | −$138,900 | — |
| Q4 2020 | 2020-12-31 | −$1.2M | $20,754 | — |
| Q3 2020 | 2020-09-30 | −$10.5M | −$1.6M | — |
| Q2 2020 | 2020-06-30 | −$982,259 | $395,039 | — |
| Q1 2020 | 2020-03-31 | −$1.2M | $95,506 | — |
| Q4 2019 | 2019-12-31 | −$1.2M | $394,844 | — |
| Q3 2019 | 2019-09-30 | −$8.9M | −$7.1M | — |
| Q2 2019 | 2019-06-30 | −$1.4M | $611,288 | — |
| Q1 2019 | 2019-03-31 | −$1.3M | $496,923 | — |
| Q4 2018 | 2018-12-31 | −$1.6M | −$6.1M | — |
| Q3 2018 | 2018-09-30 | −$1.8M | $421,609 | — |
| Q2 2018 | 2018-06-30 | −$2.0M | $908,813 | — |
| Q1 2018 | 2018-03-31 | −$1.8M | $1.0M | — |
| Q4 2017 | 2017-12-31 | $4.4M | $4.5M | — |
| Q3 2017 | 2017-09-30 | −$2.2M | $7,051 | — |
| Q2 2017 | 2017-06-30 | −$2.9M | $40.4M | — |
| Q1 2017 | 2017-03-31 | −$2.8M | −$1.0M | — |
| Q4 2016 | 2016-12-31 | −$55,231 | $2.8M | — |
| Q3 2016 | 2016-09-30 | −$2.2M | $1.5M | — |
| Q2 2016 | 2016-06-30 | −$43.3M | −$41.9M | — |
| Q1 2016 | 2016-03-31 | −$1.8M | −$35,545 | — |
| Q4 2015 | 2015-12-31 | −$2.8M | $1.4M | — |
| Q3 2015 | 2015-09-30 | −$3.8M | −$708,162 | — |
| Q2 2015 | 2015-06-30 | −$1.4M | $1.3M | — |
| Q1 2015 | 2015-03-31 | −$1.8M | $1.1M | — |
| Q4 2014 | 2014-12-31 | −$4.2M | — | — |
| Q3 2014 | 2014-09-30 | −$3.1M | −$565,116 | — |
| Q2 2014 | 2014-06-30 | −$2.6M | −$1.6M | — |
| Q1 2014 · Mar 31 | 2014-03-31 | −$2.9M | −$1.6M | — |
| Q3 2013 | 2013-09-30 | −$2.5M | — | — |
| Q2 2013 · Jun 30 | 2013-06-30 | −$1.0M | — | — |
| Q2 2013 · May 31 | 2013-05-31 | −$5,014 | $25,299 | — |
| Q1 2013 · Mar 31 | 2013-03-31 | −$1.4M | — | — |
| Q1 2013 · Feb 28 | 2013-02-28 | $23,558 | $44,312 | — |
| Q1 2013 · Nov 30 | 2012-11-30 | −$5,969 | $5,306 | — |
| Q4 2012 | 2012-08-31 | −$34,838 | — | — |
| Q3 2012 | 2012-05-31 | −$30,313 | — | — |
| Q2 2012 | 2012-02-29 | −$20,754 | — | — |
| Q1 2012 | 2011-11-30 | −$11,275 | — | — |
Xenetic Biosciences ebitda trends
Over the last five fiscal years, Xenetic Biosciences's ebitda increased from −$13.9M to −$2.8M, a change of $11.1M. The latest reported quarter, Q2 2026, shows −$971,690.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xenetic Biosciences source filings ↗